Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00092898
Status:
COMPLETED
Last Update Posted:
2022-02-16
First Post:
2004-09-23
Brief Title:
An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia 0653-062COMPLETED
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
A Multicenter Randomized Double-Blind Placebo-Controlled Study to Evaluate Efficacy and Safety of Adding Ezetimibe 30 mg to An Ongoing Regimen of Ezetimibe 10 mg in Patients Homozygous Sitosterolemia
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a 6-month study with patients who have the rare disease sitosterolemia which may result in heart-related diseases These patients have unusually high absorption of non-cholesterol sterols resulting in heart-related diseases This study investigates whether absorption of these non-cholesterols can be reduced in these patients
Detailed Description:
The duration of treatment is 26 weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004_038 | None | None | None |
| MK0653-062 | None | None | None |